Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 124 participants.

Also called NCT03096613

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 124 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03096613
Other papers using this trial's data
  • Effects of levothyroxine in subclinical hypothyroidism and heart failure with reduced ejection fraction: An open-label randomized trial Cell reports. Medicine, 2024-04-16 DOI, PubMed 38537636, PMC11031377 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03096613. Randomized; no masking; primary purpose treatment. Start 2017-04-18 (actual); primary completion 2019-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
Condition
Heart Failure
Condition
Subclinical Hypothyroidism
Intervention (Drug)
Levothyroxine
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)
Collaborator
The Luhe Teaching Hospital of the Capital Medical University (class: other)
Collaborator
Tianjin Medical University Second Hospital (class: other)
Collaborator
The First Hospital of Hebei Medical University (class: other)
Collaborator
Henan Provincial People's Hospital (class: other)

Record details

Record id
cardio:ct-nct03096613
Content hash
8dc6862771701b22908dc659fcbf58b415feba4d4c5826beba4cecfc6058d8d6